Journal
JOURNAL OF ADDICTION MEDICINE
Volume 16, Issue 6, Pages 722-724Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/ADM.0000000000000969
Keywords
drug testing; overdose; substance use
Categories
Funding
- Johns Hopkins Center for AIDS Research [1P30AI094189]
- National Institutes of Health [5R03DA049998]
- National Institute for Drug Abuse [T32DA007292]
- Behavioral Health System Baltimore [AS019HRO-JHPH]
Ask authors/readers for more resources
This study aimed to measure the concordance between self-reported and biologically tested fentanyl exposure. The study found that only 54% of participants who reported daily fentanyl use had a positive result in biological testing, indicating low agreement between self-reporting and biological detection.
Drug overdose remains a leading cause of death in the US, and the majority of opioid overdose fatalities involve fentanyl. This study aims to measure the degree of concordance between self-reported and biologically tested exposure to fentanyl. We conducted a cross-sectional analysis using survey and urinalysis data collected between 2019 and 2020 from Anne Arundel County, Maryland. Among urinalysis participants (n =113), 30% reported daily fentanyl use, and among this group, only 54% had a fentanyl-positive result. Cohen Kappa between self-reported and biologically detected fentanyl use was 0.26, indicating minimal agreement between the 2 markers. Limitations to interpreting self-reported and urinalysis data are discussed in this report.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available